7Manches O, Lui G, Chaperot L, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas[J]. Blood, 2003,101 (3) : 949-954.
8Forero A, Lobuglio AF.History of antibody therapy for non-Hodgkin's lymphoma[]]. Semin Oncol, 2003, 30(6 Suppl 17): 1-5.
9VoseJM, Link BK, Grossbard ML, et al. Phase Ⅱ study of rituximab in combination with chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma[J]. J Clin Oncol, 2001, 19(2): 389-397.
10Coiffier B, Haioun C, Ketterer N, et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of padents with relapsing or refractory aggressive lyrnphoma: a multicenter phase Ⅱ study [J]. Blood, 1998, 92(6): 1927-1932.
2British Committee for Stangards in Haematology General Haematology Task Force.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults.children and in pregnancy[J].Br J Haematol,2003,120(4):574-596.
3Levesque MC,St Clair EW,B cell-directed therapies for autoim mune disease and correlates of disease response and relapse[J].J Allergy Clin Immunol,2008,121(1):13-21.
4Okur FV,Oguz A,Kaadeniz C,et al.Refractoriness to rituximab mono-therapy in a child with relapsed/efractory Bukitt non-Hodgkin lym-phoma[J].Pediatr Hematol Onmol,2006,23(1):25-31.
5Imamura T.Yoshihara T,Mohmoto A,et al.Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma[J].Pediatric Hematology and Oncology,2006,23(1):19-24.
6Levesque M C, St Clair E W. B cell - directed therapies for autoimmune disease and correlates of disease response and relapse[J]. J Allergy Clin Immunol, 2008, 121 : 13.
7British Committee for Stangards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol, 2003, 120: 574.
8Okur F V, Oguz A, Karadeniz C. Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non- Hodgkin lymphoma[J]. Pediatr Hematolcol, 2006, 23(01) : 25.
9lmamura T, Yoshihara T, Morimoto A. Sucessful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B - cell lymphoma[J]. Pediatric Hematology and Oneotogy, 2006, 23(01): 19.
